Cargando…

Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study

Indoor mold infestation can lead to a variety of adverse health effects, including allergic and non-allergic respiratory complaints. Especially if no evidence of an allergic reaction can be found for the complaints, diagnostic tools that might explain mold-associated health problems are missing. As...

Descripción completa

Detalles Bibliográficos
Autores principales: Liebers, Verena, Kespohl, Sabine, Borowitzki, Gerda, Stubel, Heike, Raulf, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982069/
https://www.ncbi.nlm.nih.gov/pubmed/35392213
http://dx.doi.org/10.5414/ALX02299E
_version_ 1784681731491627008
author Liebers, Verena
Kespohl, Sabine
Borowitzki, Gerda
Stubel, Heike
Raulf, Monika
author_facet Liebers, Verena
Kespohl, Sabine
Borowitzki, Gerda
Stubel, Heike
Raulf, Monika
author_sort Liebers, Verena
collection PubMed
description Indoor mold infestation can lead to a variety of adverse health effects, including allergic and non-allergic respiratory complaints. Especially if no evidence of an allergic reaction can be found for the complaints, diagnostic tools that might explain mold-associated health problems are missing. As a proof-of-concept, in the present study whole blood assay (WBA) was used to determine cellular response by measuring cytokine release (IL-1β and IL-8) after in vitro stimulation. Blood was available from a total of 48 subjects. By questionnaire, complaints and possible mold exposure were documented. Specific in vitro blood stimulation was tested with Escherichia coli endotoxin and extracts of different molds (Aspergillus fumigatus, Penicillium chrysogenum, Aspergillus versicolor, and Cladosporium herbarum). To characterize the relevance of WBA in describing the mold-induced immune response, we compared the following groups: asthmatics vs. non-asthmatics, mx1-sensitized vs. non-mx1-sensitized, mold-exposed vs. non-mold-exposed. In response to endotoxin stimulation, a significantly higher IL-1β release was found in mx1-sensitized than in non-mx1-sensitized subjects. Furthermore, the blood of asthmatics showed significantly higher IL-8 and IL-1β release after stimulation with Penicillium chrysogenum and endotoxin, respectively, compared to non-asthmatics. However, no significant difference in the level of cytokine release was observed between the mold-exposed and non-exposed group, neither after endotoxin nor mold stimulation. In conclusion, the WBA used in this study is not a suitable tool for clinical routine diagnostic workup. Our data suggests that WBA reflects cellular differences that are disease-related but not directly attributable to mold exposure. However, in combination with further data, WBA will be a helpful und interesting tool in research, e.g., in description of the complex immune response to molds.
format Online
Article
Text
id pubmed-8982069
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dustri-Verlag Dr. Karl Feistle
record_format MEDLINE/PubMed
spelling pubmed-89820692022-04-06 Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study Liebers, Verena Kespohl, Sabine Borowitzki, Gerda Stubel, Heike Raulf, Monika Allergol Select Research Article Indoor mold infestation can lead to a variety of adverse health effects, including allergic and non-allergic respiratory complaints. Especially if no evidence of an allergic reaction can be found for the complaints, diagnostic tools that might explain mold-associated health problems are missing. As a proof-of-concept, in the present study whole blood assay (WBA) was used to determine cellular response by measuring cytokine release (IL-1β and IL-8) after in vitro stimulation. Blood was available from a total of 48 subjects. By questionnaire, complaints and possible mold exposure were documented. Specific in vitro blood stimulation was tested with Escherichia coli endotoxin and extracts of different molds (Aspergillus fumigatus, Penicillium chrysogenum, Aspergillus versicolor, and Cladosporium herbarum). To characterize the relevance of WBA in describing the mold-induced immune response, we compared the following groups: asthmatics vs. non-asthmatics, mx1-sensitized vs. non-mx1-sensitized, mold-exposed vs. non-mold-exposed. In response to endotoxin stimulation, a significantly higher IL-1β release was found in mx1-sensitized than in non-mx1-sensitized subjects. Furthermore, the blood of asthmatics showed significantly higher IL-8 and IL-1β release after stimulation with Penicillium chrysogenum and endotoxin, respectively, compared to non-asthmatics. However, no significant difference in the level of cytokine release was observed between the mold-exposed and non-exposed group, neither after endotoxin nor mold stimulation. In conclusion, the WBA used in this study is not a suitable tool for clinical routine diagnostic workup. Our data suggests that WBA reflects cellular differences that are disease-related but not directly attributable to mold exposure. However, in combination with further data, WBA will be a helpful und interesting tool in research, e.g., in description of the complex immune response to molds. Dustri-Verlag Dr. Karl Feistle 2022-03-29 /pmc/articles/PMC8982069/ /pubmed/35392213 http://dx.doi.org/10.5414/ALX02299E Text en © Dustri-Verlag Dr. K. Feistle https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liebers, Verena
Kespohl, Sabine
Borowitzki, Gerda
Stubel, Heike
Raulf, Monika
Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title_full Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title_fullStr Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title_full_unstemmed Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title_short Is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? A proof-of-concept study
title_sort is in vitro cytokine release a suitable marker to improve the diagnosis of suspected mold-related respiratory symptoms? a proof-of-concept study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982069/
https://www.ncbi.nlm.nih.gov/pubmed/35392213
http://dx.doi.org/10.5414/ALX02299E
work_keys_str_mv AT liebersverena isinvitrocytokinereleaseasuitablemarkertoimprovethediagnosisofsuspectedmoldrelatedrespiratorysymptomsaproofofconceptstudy
AT kespohlsabine isinvitrocytokinereleaseasuitablemarkertoimprovethediagnosisofsuspectedmoldrelatedrespiratorysymptomsaproofofconceptstudy
AT borowitzkigerda isinvitrocytokinereleaseasuitablemarkertoimprovethediagnosisofsuspectedmoldrelatedrespiratorysymptomsaproofofconceptstudy
AT stubelheike isinvitrocytokinereleaseasuitablemarkertoimprovethediagnosisofsuspectedmoldrelatedrespiratorysymptomsaproofofconceptstudy
AT raulfmonika isinvitrocytokinereleaseasuitablemarkertoimprovethediagnosisofsuspectedmoldrelatedrespiratorysymptomsaproofofconceptstudy